Fragmentomic analysis of circulating tumor DNA-targeted cancer panelsKyle T. Helzer, Shuang G. Zhao, Marina N. Sharifi et al.|Annals of Oncology|2023Cited by 70
Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate CancerJamie M. Sperger, Joshua M. Lang, Kyle T. Helzer et al.|Clinical Cancer Research|2023Cited by 56
A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancerShuang G. Zhao, Joshua M. Lang, Nicholas R. Rydzewski et al.|Journal of Clinical Investigation|2022Cited by 33
Longitudinal Molecular Profiling of Circulating Tumor Cells in Metastatic Renal Cell CarcinomaMatthew L. Bootsma, Shuang G. Zhao, Rana R. McKay et al.|Journal of Clinical Oncology|2022Cited by 28
Adverse prognosis gene expression patterns in metastatic castration‐resistant prostate cancerMarina N. Sharifi, Martin Sjöström, Eric Feng et al.|Molecular Oncology|2025Cited by 4